Admission Date:  [**2164-1-1**]              Discharge Date:   [**2164-1-11**]  Date of Birth:  [**2125-5-27**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Aspirin  Attending:[**Last Name (NamePattern1) 4377**] Chief Complaint: Fever  Major Surgical or Invasive Procedure: Placement of Peripherally inserted central venous catheter x 2 Central line placement   History of Present Illness: 38F with Burkit's lymphoma of ovary, currently on chemo therapy, presenting with acute onset fever.
Pt was recently admitted for IVAC and intrathecal MTX treatment, and was d/c'ed home on [**12-25**].
She underwent left ophorectomy in [**2163-10-6**], and started alternating CODOX-M (cyclophosphamide, doxorubicin, Adriamycin, vincristine with intrathecal methotrexate and cytarabine followed by high-dose systemic methotrexate) with IVAC (ifosfamide, cytarabine, etoposide and intrathecal methotrexate).
Pt had 3L NS, Vancomycin and Cefepime.
Pt has a PICC line placed in [**Month (only) **].
Denies chest pain, chest pressure, palpitations.
- [**2163-10-20**] BMBx negative for involvement by lymphoma - [**2163-10-21**] C1D1 CODOX-M with IT Cytarabine 70 mg D1, VinCRIStine 2 mg D1,8, DOXOrubicin 40 mg/m2 D1, Cyclophosphamide 800 mg/m2 D1 and 200 mg/m2 D2,3,4,5, Methotrexate 1200 mg/m2 bolus D10 and 5520 mg/m2 infused over 23 hours on D10, and IT Methotrexate 12 mg D15 - [**2163-10-22**] CSF cytology negative for involvement by lymphoma - [**2163-10-30**] HD Methotrexate 3000 mg/m2 with leucovorin rescue - [**2163-11-4**] IT Methotrexate 25 mg - [**2163-11-9**] C1D1 IVAC Etoposide 60 mg/m2 D1,2,3,4,5, Ifosfamide 1500 mg/m2 D1,2,3,4,5 with Mesna, and Cytarabine [**2152**] mg/m2 D1,2 - [**2163-11-28**] C2D1 CODOX-M with VinCRIStine 1.5 mg/m2 caped at 2 mg D1,8, DOXOrubicin 40 mg/m2 D1, Cyclophosphamide 800 mg/m2 D1, Cyclophosphamide 200 mg/m2 D2,3,4,5, and Methotrexate 3500 mg/m2 D10 with Leucovorin rescue.
- [**2163-11-28**] C1 Rituximab 375 mg/m2 - [**2163-12-5**] C2 Rituximab 375 mg/m2 - [**2163-12-19**]- [**12-25**] IVAC C2 etoposide 60 mg/m2 and ifosfamide 1500 mg/m2 D1-5, cytarabine [**2152**] mg/m2 Q12H D1,2, and IT methotrexate 12 mg with hydrocortisone 25 mg D5 .
Test                          Result              Reference Range/Units M.PNEUMONIAE AB  IGG, EIA     1.52  H             <=0.90 ISR   Reference Ranges:  <=0.90     Negative - no Mycoplasma Pneumoniae                        Antibody detected  0.91-1.09  Equivocal  >=1.10     Positive - Mycoplasma Pneumoniae                        Antibody detected .
Test Name                       In Range     Out of Range Reference Range ---------                       --------     ------------ --------------- Adenovirus DNA, Quantitative Real-Time PCR   Adenovirus DNA, Qn PCR     No DNA Detected <500 Copies/mL  This test was developed and its performance characteristics have been determined by Focus Diagnostics.
Test ---- Fungitell (tm) Assay for (1,3)-B-D-Glucans  Results                                 Reference Ranges -------                                 ---------------- <31 pg/mL                               Negative       Less than 60 pg/mL                                         Indeterminate  60 - 79 pg/mL                                         Positive       Greater than or                        equal to 80 pg/mL  .
CLINDAMYCIN = <=0.12 MCG/ML.
Legionella Urinary Antigen  (Final [**2164-1-2**]):       NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN.
Furthermore, in       infected patients the excretion of antigen in urine may vary.
CATHETER TIP-IV      Source: PICC line.
The change is likely due to new lymph node enlargement, difficult to demonstrate in the absence of intravenous contrast infusion.
A left-sided central venous catheter ends in the upper right atrium.
She was started on broad spectrum antibiotics however continued to spike despite broad spectrum antibiotics.
Viral studies including adenovirus PCR and viral sputum culture were negative.
Patient was broadly covered with vancomycin, cefepime, micafungin, and flagyl with subsequent negative blood cultures.
When b-glucan and galactomannan were both negative, micafungin was discontinued and fluconazole was restarted.
Fluconazole was discontinued when the patients WBC increased.
Cefepime was discontinued given there was no evidence of gram negative bacterial infection.
ID was consulted and recommended adding levofloxacin for empiric coverage of atypical pneumonia for a planned 7 day course.
PICC line was replaced and she was transitioned to ceftriaxone for a planned 4 week course.
The patient was diuresed initially with lasix gtt then lasix boluses with symptomatic improvement.
Cardiology was consulted and recommended initiation of IV lopressor with transition to oral TID lopressor with improvement in rate.
This medication was discontinued as HR improved.
# Cardiomyopathy:  Initial transthoracic echocardiogram was concerning for dilated cardiomyopathy.
She was supported with transfusion of PRBCs and platelets to keep Hct<24 and plt<20.
She was initially continued on neupogen dose 480mcg.
Counts improved over the course of admission and neupogen was discontinued.
Continued Acyclovir and Bactrim prophylaxis.
She is scheduled for a repeat PET as an outpatient.
TRANSITIONAL ISSUES - Patient will follow-up with Dr. [**First Name (STitle) **] - Patient was full code throughout this admission  Medications on Admission: 1. acyclovir 400 mg q8h 2. butalbital-acetaminophen-caff 50-325-40 mg qd prn headache 3. clotrimazole 10 mg Troche tid prn mucosa membrane 4. norethindrone acetate 5 mg qd 5. omeprazole 20 mg Capsule qd 6. prochlorperazine maleate 10 mg q6 prn nausea 7. sulfamethoxazole-trimethoprim 400-80 mg qd 8. lamivudine 100 mg qd 9. docusate sodium 100 mg qd when on narcotics 10.
Neupogen 300 mcg/mL Solution Sig: One (1) injection (300 mcg) Injection once a day: To start on [**12-26**].
11. lorazepam 0.5 mg q6-8 h prn anxiety 12.
Ciprofloxacin 500 mg qd 13. fluconazole 200 mg qd   Discharge Medications: 1. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours).
2. sulfamethoxazole-trimethoprim 400-80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
3. lamivudine 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. norethindrone acetate 5 mg Tablet Sig: One (1) Tablet PO daily ().
5. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for anxiety.
6. ceftriaxone in dextrose,iso-os 2 gram/50 mL Piggyback Sig: Two (2) gram  Intravenous Q24H (every 24 hours) for 18 days.
Disp:*36 gram * Refills:*0* 7. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO DAILY (Daily) for 2 days.
Disp:*100 ML(s)* Refills:*0* 9. benzonatate 100 mg Capsule Sig: Two (2) Capsule PO TID (3 times a day) as needed for cough.
Disp:*30 Capsule(s)* Refills:*0* 10. clotrimazole 10 mg Troche Sig: One (1)  Mucous membrane three times a day as needed for mucosal irritation.
11. omeprazole 20 mg Capsule, Delayed Release(E.C.)
12. prochlorperazine maleate 10 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for nausea.
13. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO once a day as needed for constipation.
You started on antibiotics through your IV which you will need to continue until [**1-29**].
You were given medications to help remove this fluid and to help control your heart rate.
A repeat ultrasound of your heart was normal.
We made the following changes to your medications 1.
START Ceftriaxone 2 g daily for 18 more days 2.
START Levofloxacin for 2 more days 3.
START codeine-guaifenesin as needed for cough 4.
STOP Fluconazole  You should continue to take all other medications as instructed.
